Antimicrobial catheters in the ICU: is the juice worth the squeeze?

doi:10.1186/cc7793

Critical Care

Volume 13
Issue 3

Viewing options:

Abstract
Full text
PDF (44KB)

Associated material:

Related literature:

Articles citing this article
on Google Scholar
on ISI Web of Science
on PubMed Central
Other articles by authors
on Google Scholar

Safdar N

on PubMed

Safdar N
Related articles/pages
on Google

on Google Scholar

on PubMed

Tools:

Post to:

Commentary

Antimicrobial catheters in the ICU: is the juice worth the squeeze?

Nasia Safdar

Section of Infectious Diseases, Department of Medicine, University of Wisconsin Medical School, H4/572, 600 Highland Avenue, Madison, WI 53792, USA

author email corresponding author email

Critical Care 2009, 13:148doi:10.1186/cc7793


Published:	20 May 2009

See related research by Halton et al., http://ccforum.com/content/13/2/R35

Abstract

Catheter-related bloodstream infection is one of the most serious complications of central venous access devices. Antimicrobial-coated catheters represent one novel strategy to prevent catheter-related bloodstream infection. A comprehensive economic evaluation is essential to guide informed decision-making regarding the adoption of this technology and its expected benefits in healthcare institutions.